The objectives of the study were to assess the ability of the Femcap(R
), a new vaginal contraceptive device made of silicone and designed to
fit snugly around the cervix to prevent the penetration of sperm into
midcycle cervical mucus when used with and without spermicide; and to
compare it with the standard contraceptive diaphragm used with spermi
cide. Eight women underwent two baseline cycles of postcoital tasting
in which no device was used, followed by three test cycles in which Fe
mcap with spermicide, Femcap with nonspermicidal lubricant (KY(R) gel)
or the Ortho All-Flex(R) diaphragm with spermicide was used. The sequ
ence of testing cycles was randomized.In each cycle, condoms were used
prior to midcycle, then a midcycle cervical mucus specimen was examin
ed to ensure midcycle characteristics and the absence of sperm. Each w
oman then had intercourse using either no device (baseline cycles) or
the prescribed device (test cycles) and returned 2-3 h afterwards. Cer
vical mucus was again assessed for adequacy and the presence of sperma
tozoa. The average number of progressively motile sperm seen per high
power field was as follows: first baseline cycle, 18.0; second baselin
e cycle, 17.8; test cycle with Femcap used with nonspermicidal lubrica
nt, 0.1, test cycle with Femcap used with spermicide, 0.2; and test cy
cle with the diaphragm used with spermicide, 0.0. There was no signifi
cant difference between baseline cycles or among test cycles in the av
erage number of progressively motile sperm seen (p > 0.05). The averag
e number of progressively motile sperm seen in each test cycle did, ho
wever, differ significantly from the average number seen in either bas
eline cycle (p < 0.05). Femcap, used with either a spermicidal lubrica
nt or a nonspermicidal lubricant, appears to be comparable with the di
aphragm used with spermicide in preventing sperm from entering midcycl
e cervical mucus. (C) 1997 Elsevier Science Inc. All rights reserved.